This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Forbes
forbes.com
did:plc:2w45zyhuklwihpdc7oj3mi63
Novo’s CagriSema shot was shown to be less effective than rival Lilly’s tirzepatide
http://www.forbes.com/sites/martinadilicosa/2026/02/23/novo-nordisks-new-weight-loss-shot-loses-to-rival-eli-lilly-in-clinical-trial-stock-plummets/?utm_campaign=forbes&utm_medium=social&utm_source=bluesky
2026-02-23T14:30:07.559Z